103 related articles for article (PubMed ID: 9492010)
1. Troglitazone increases system A amino acid transport in 3T3-L1 cells.
Su TZ; Wang M; Oxender DL; Saltiel AR
Endocrinology; 1998 Mar; 139(3):832-7. PubMed ID: 9492010
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
Tafuri SR
Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
[TBL] [Abstract][Full Text] [Related]
3. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
Barthel A; Krüger KD; Roth RA; Joost HG
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):290-5. PubMed ID: 11919653
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.
Anil Kumar KL; Marita AR
Br J Pharmacol; 2000 May; 130(2):351-8. PubMed ID: 10807673
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells.
Ohsumi J; Sakakibara S; Yamaguchi J; Miyadai K; Yoshioka S; Fujiwara T; Horikoshi H; Serizawa N
Endocrinology; 1994 Nov; 135(5):2279-82. PubMed ID: 7956951
[TBL] [Abstract][Full Text] [Related]
6. Insulin-stimulated methylaminoisobutyric acid uptake in 3T3-L1 fibroblasts and fat cells.
Grunfeld C; Jones DS
Endocrinology; 1983 Nov; 113(5):1763-70. PubMed ID: 6354697
[TBL] [Abstract][Full Text] [Related]
7. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes.
Ranganathan S; Kern PA
J Biol Chem; 1998 Oct; 273(40):26117-22. PubMed ID: 9748292
[TBL] [Abstract][Full Text] [Related]
9. Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
Skurk T; Birgel M; Lee YM; Hauner H
Metabolism; 2006 Mar; 55(3):309-16. PubMed ID: 16483873
[TBL] [Abstract][Full Text] [Related]
10. PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes.
Camp HS; Whitton AL; Tafuri SR
FEBS Lett; 1999 Mar; 447(2-3):186-90. PubMed ID: 10214942
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes.
Emoto M; Anno T; Sato Y; Tanabe K; Okuya S; Tanizawa Y; Matsutani A; Oka Y
Diabetes; 2001 May; 50(5):1166-70. PubMed ID: 11334422
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
Wang M; Wise SC; Leff T; Su TZ
Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes.
Kurebayashi S; Hirose T; Miyashita Y; Kasayama S; Kishimoto T
Diabetes; 1997 Dec; 46(12):2115-8. PubMed ID: 9392507
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo study in 3T3-L1 cells and Otsuka Long-Evans Tokushima Fatty rats.
Dobashi K; Asayama K; Nakane T; Kodera K; Hayashibe H; Nakazawa S
Life Sci; 2000 Sep; 67(17):2093-101. PubMed ID: 11057759
[TBL] [Abstract][Full Text] [Related]
16. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells.
Shojima N; Sakoda H; Ogihara T; Fujishiro M; Katagiri H; Anai M; Onishi Y; Ono H; Inukai K; Abe M; Fukushima Y; Kikuchi M; Oka Y; Asano T
Diabetes; 2002 Jun; 51(6):1737-44. PubMed ID: 12031960
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.
Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
J Clin Endocrinol Metab; 1998 May; 83(5):1636-43. PubMed ID: 9589670
[TBL] [Abstract][Full Text] [Related]
18. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes.
Rudich A; Tirosh A; Potashnik R; Khamaisi M; Bashan N
Diabetologia; 1999 Aug; 42(8):949-57. PubMed ID: 10491755
[TBL] [Abstract][Full Text] [Related]
19. C(2)-ceramide influences the expression and insulin-mediated regulation of cyclic nucleotide phosphodiesterase 3B and lipolysis in 3T3-L1 adipocytes.
Mei J; Holst LS; Landström TR; Holm C; Brindley D; Manganiello V; Degerman E
Diabetes; 2002 Mar; 51(3):631-7. PubMed ID: 11872660
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor Fos-related antigen 1 is induced by thiazolidinediones during differentiation of 3T3-L1 cells.
Albrektsen T; Fleckner J
Mol Pharmacol; 2001 Mar; 59(3):567-75. PubMed ID: 11179452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
